• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of prosciprotein sciencecshl presssubscriptionsetoc alertsthe protein societyjournal home
Protein Sci. Aug 1999; 8(8): 1668–1674.
PMCID: PMC2144417

Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused.


Although it is usually possible to achieve a favorable yield of a recombinant protein in Escherichia coli, obtaining the protein in a soluble, biologically active form continues to be a major challenge. Sometimes this problem can be overcome by fusing an aggregation-prone polypeptide to a highly soluble partner. To study this phenomenon in greater detail, we compared the ability of three soluble fusion partners--maltose-binding protein (MBP), glutathione S-transferase (GST), and thioredoxin (TRX)--to inhibit the aggregation of six diverse proteins that normally accumulate in an insoluble form. Remarkably, we found that MBP is a far more effective solubilizing agent than the other two fusion partners. Moreover, we demonstrated that in some cases fusion to MBP can promote the proper folding of the attached protein into its biologically active conformation. Thus, MBP seems to be capable of functioning as a general molecular chaperone in the context of a fusion protein. A model is proposed to explain how MBP promotes the solubility and influences the folding of its fusion partners.

Full Text

The Full Text of this article is available as a PDF (553K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Aoki T, Tomaki E, Satoh M, Takashiro M, Onagi H, Itoh M, Teramoto T, Morikawa J, Watabe H. Purification of recombinant human pepsinogens and their application as immunoassay standards. Biochem Mol Biol Int. 1998 Jun;45(2):289–301. [PubMed]
  • Blondel A, Nageotte R, Bedouelle H. Destabilizing interactions between the partners of a bifunctional fusion protein. Protein Eng. 1996 Feb;9(2):231–238. [PubMed]
  • Buckle AM, Zahn R, Fersht AR. A structural model for GroEL-polypeptide recognition. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3571–3575. [PMC free article] [PubMed]
  • Butt TR, Jonnalagadda S, Monia BP, Sternberg EJ, Marsh JA, Stadel JM, Ecker DJ, Crooke ST. Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2540–2544. [PMC free article] [PubMed]
  • Calderone TL, Stevens RD, Oas TG. High-level misincorporation of lysine for arginine at AGA codons in a fusion protein expressed in Escherichia coli. J Mol Biol. 1996 Oct 4;262(4):407–412. [PubMed]
  • Chen GQ, Gouaux JE. Overexpression of bacterio-opsin in Escherichia coli as a water-soluble fusion to maltose binding protein: efficient regeneration of the fusion protein and selective cleavage with trypsin. Protein Sci. 1996 Mar;5(3):456–467. [PMC free article] [PubMed]
  • Cormack BP, Valdivia RH, Falkow S. FACS-optimized mutants of the green fluorescent protein (GFP). Gene. 1996;173(1 Spec No):33–38. [PubMed]
  • Crameri A, Whitehorn EA, Tate E, Stemmer WP. Improved green fluorescent protein by molecular evolution using DNA shuffling. Nat Biotechnol. 1996 Mar;14(3):315–319. [PubMed]
  • Derbyshire KM, Grindley ND. Binding of the IS903 transposase to its inverted repeat in vitro. EMBO J. 1992 Sep;11(9):3449–3455. [PMC free article] [PubMed]
  • Fenton WA, Kashi Y, Furtak K, Horwich AL. Residues in chaperonin GroEL required for polypeptide binding and release. Nature. 1994 Oct 13;371(6498):614–619. [PubMed]
  • Hering TM, Kollar J, Huynh TD, Varelas JB. Purification and characterization of decorin core protein expressed in Escherichia coli as a maltose-binding protein fusion. Anal Biochem. 1996 Aug 15;240(1):98–108. [PubMed]
  • Kimata Y, Iwaki M, Lim CR, Kohno K. A novel mutation which enhances the fluorescence of green fluorescent protein at high temperatures. Biochem Biophys Res Commun. 1997 Mar 6;232(1):69–73. [PubMed]
  • LaVallie ER, DiBlasio EA, Kovacic S, Grant KL, Schendel PF, McCoy JM. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Biotechnology (N Y) 1993 Feb;11(2):187–193. [PubMed]
  • Lorenzo HK, Farber D, Germain V, Acuto O, Alzari PM. The MBP fusion protein restores the activity of the first phosphatase domain of CD45. FEBS Lett. 1997 Jul 14;411(2-3):231–235. [PubMed]
  • Louis JM, McDonald RA, Nashed NT, Wondrak EM, Jerina DM, Oroszlan S, Mora PT. Autoprocessing of the HIV-1 protease using purified wild-type and mutated fusion proteins expressed at high levels in Escherichia coli. Eur J Biochem. 1991 Jul 15;199(2):361–369. [PubMed]
  • Lu Z, DiBlasio-Smith EA, Grant KL, Warne NW, LaVallie ER, Collins-Racie LA, Follettie MT, Williamson MJ, McCoy JM. Histidine patch thioredoxins. Mutant forms of thioredoxin with metal chelating affinity that provide for convenient purifications of thioredoxin fusion proteins. J Biol Chem. 1996 Mar 1;271(9):5059–5065. [PubMed]
  • Martineau P, Saurin W, Hofnung M, Spurlino JC, Quiocho FA. Progress in the identification of interaction sites on the periplasmic maltose binding protein from E coli. Biochimie. 1990 Jun-Jul;72(6-7):397–402. [PubMed]
  • Mottershead DG, Polly P, Lyons RJ, Sutherland RL, Watts CK. High activity, soluble, bacterially expressed human vitamin D receptor and its ligand binding domain. J Cell Biochem. 1996 Jun 1;61(3):325–337. [PubMed]
  • Nygren PA, Ståhl S, Uhlén M. Engineering proteins to facilitate bioprocessing. Trends Biotechnol. 1994 May;12(5):184–188. [PubMed]
  • Parks TD, Howard ED, Wolpert TJ, Arp DJ, Dougherty WG. Expression and purification of a recombinant tobacco etch virus NIa proteinase: biochemical analyses of the full-length and a naturally occurring truncated proteinase form. Virology. 1995 Jun 20;210(1):194–201. [PubMed]
  • Pérez-Martin J, Cases I, de Lorenzo V. Design of a solubilization pathway for recombinant polypeptides in vivo through processing of a bi-protein with a viral protease. Protein Eng. 1997 Jun;10(6):725–730. [PubMed]
  • Power RF, Conneely OM, McDonnell DP, Clark JH, Butt TR, Schrader WT, O'Malley BW. High level expression of a truncated chicken progesterone receptor in Escherichia coli. J Biol Chem. 1990 Jan 25;265(3):1419–1424. [PubMed]
  • Prasher DC, Eckenrode VK, Ward WW, Prendergast FG, Cormier MJ. Primary structure of the Aequorea victoria green-fluorescent protein. Gene. 1992 Feb 15;111(2):229–233. [PubMed]
  • Pryor KD, Leiting B. High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system. Protein Expr Purif. 1997 Aug;10(3):309–319. [PubMed]
  • Rao S, Bodley JW. Expression, purification, and characterization of the G domain of Saccharomyces cerevisiae elongation factor 2. Protein Expr Purif. 1996 Aug;8(1):91–96. [PubMed]
  • Reddy A, Grimwood BG, Plummer TH, Tarentino AL. High-level expression of the Endo-beta-N-acetylglucosaminidase F2 gene in E.coli: one step purification to homogeneity. Glycobiology. 1998 Jun;8(6):633–636. [PubMed]
  • Richarme G, Caldas TD. Chaperone properties of the bacterial periplasmic substrate-binding proteins. J Biol Chem. 1997 Jun 20;272(25):15607–15612. [PubMed]
  • Robben J, Van der Schueren J, Volckaert G. Carboxyl terminus is essential for intracellular folding of chloramphenicol acetyltransferase. J Biol Chem. 1993 Nov 25;268(33):24555–24558. [PubMed]
  • Saavedra-Alanis VM, Rysavy P, Rosenberg LE, Kalousek F. Rat liver mitochondrial processing peptidase. Both alpha- and beta-subunits are required for activity. J Biol Chem. 1994 Mar 25;269(12):9284–9288. [PubMed]
  • Sachdev D, Chirgwin JM. Solubility of proteins isolated from inclusion bodies is enhanced by fusion to maltose-binding protein or thioredoxin. Protein Expr Purif. 1998 Feb;12(1):122–132. [PubMed]
  • Sachdev D, Chirgwin JM. Order of fusions between bacterial and mammalian proteins can determine solubility in Escherichia coli. Biochem Biophys Res Commun. 1998 Mar 27;244(3):933–937. [PubMed]
  • Samuelsson E, Moks T, Nilsson B, Uhlen M. Enhanced in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner. Biochemistry. 1994 Apr 12;33(14):4207–4211. [PubMed]
  • Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature. 1993 Dec 16;366(6456):704–707. [PubMed]
  • Siemering KR, Golbik R, Sever R, Haseloff J. Mutations that suppress the thermosensitivity of green fluorescent protein. Curr Biol. 1996 Dec 1;6(12):1653–1663. [PubMed]
  • Spurlino JC, Lu GY, Quiocho FA. The 2.3-A resolution structure of the maltose- or maltodextrin-binding protein, a primary receptor of bacterial active transport and chemotaxis. J Biol Chem. 1991 Mar 15;266(8):5202–5219. [PubMed]
  • Studier FW, Rosenberg AH, Dunn JJ, Dubendorff JW. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 1990;185:60–89. [PubMed]
  • Thomas S, Soriano S, d'Santos C, Banting G. Expression of recombinant rat myo-inositol 1,4,5-trisphosphate 3-kinase B suggests a regulatory role for its N-terminus. Biochem J. 1996 Nov 1;319(Pt 3):713–716. [PMC free article] [PubMed]
  • Uhlén M, Forsberg G, Moks T, Hartmanis M, Nilsson B. Fusion proteins in biotechnology. Curr Opin Biotechnol. 1992 Aug;3(4):363–369. [PubMed]
  • Uhlén M, Nilsson B, Guss B, Lindberg M, Gatenbeck S, Philipson L. Gene fusion vectors based on the gene for staphylococcal protein A. Gene. 1983 Sep;23(3):369–378. [PubMed]
  • Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. FASEB J. 1993 Jul;7(10):872–879. [PubMed]
  • Williamson RA, Martorell G, Carr MD, Murphy G, Docherty AJ, Freedman RB, Feeney J. Solution structure of the active domain of tissue inhibitor of metalloproteinases-2. A new member of the OB fold protein family. Biochemistry. 1994 Oct 4;33(39):11745–11759. [PubMed]
  • Yang TT, Cheng L, Kain SR. Optimized codon usage and chromophore mutations provide enhanced sensitivity with the green fluorescent protein. Nucleic Acids Res. 1996 Nov 15;24(22):4592–4593. [PMC free article] [PubMed]
  • Zhang Y, Olsen DR, Nguyen KB, Olson PS, Rhodes ET, Mascarenhas D. Expression of eukaryotic proteins in soluble form in Escherichia coli. Protein Expr Purif. 1998 Mar;12(2):159–165. [PubMed]

Articles from Protein Science : A Publication of the Protein Society are provided here courtesy of The Protein Society


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...